General Gut Inflammation
Of the 1 unique stories with a clear outcome, 1 reported it helped (100%).
These are public YouTube testimonials, not clinical evidence. People who tried BPC-157 and got no result rarely post videos — read this as a sample of the positive end of the distribution.
“gut symptoms that nothing else touched begin to resolve”
Related research
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.
This review concludes that BPC-157 has therapeutic potential in addressing electrolyte imbalances, including hyperkalemia, hypokalemia, hypermagnesemia, and hyperlithiemia, by counteracting adverse effects and promoting recovery. The peptide demonstrated comprehensive counteractive effects in various studies, including in vitro and in vivo experiments.
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.
This review concludes that BPC-157 has pleiotropic beneficial effects, controlling and modulating angiogenesis and the NO-system, and shows promise in wound healing and counteracting neurodegenerative diseases. BPC-157 also exhibits anti-tumor potential and does not produce corneal neovascularization.
Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint.
The study found that BPC-157, a stable gastric pentadecapeptide, rapidly induces vessel recruitment and healing in rats with duodenocolic fistulas, leading to closed defects and resolved leakage. All BPC-157-treated rats showed significant improvement, with no fistula leakage, diarrhea, or weight loss, and reduced adhesion formation and intestinal obstruction.
Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats.
BPC-157 therapy was shown to effectively counteract reperfusion-induced occlusion syndrome and reduce organ lesions and thrombosis in rats with severe intra-abdominal hypertension. The therapy also promoted vascular recovery and reversed previous ischemia-course lesions.